Portugal, June 2 -- Portugal based GlaxoSmithkline - Produtos Farmaceuticos, Lda. has secured contract from Instituto Portugues de Oncologia do Porto Francisco Gentil, EPE for Pharmaceutical products Dostarlimab 50 mg ml sol Inj Frs 10 ml IV . The value of the contract is worth 10000.0 EUR .
Published by HT Digital Content Services with permission from Pivotal Sources....